Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by CHASE WILLIAM J. Director active across 2 companies, notably Intellia Therapeutics, Inc.. Aggregated, 9 reports have been logged. History available since 14 April 2023. The latest transaction was filed on 29 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
6,082 shares@ US$41.1080.2% of flowCommon StockSEC:0001699031-25-000129:0
784 shares@ US$25.946.6% of flowCommon StockSEC:0001699031-25-000084:0
1,182 shares@ US$17.587.4% of flowCommon StockSEC:0001628280-25-001746:0
210 shares@ US$13.621.0% of flowCommon StockSEC:0001628280-24-044798:0
1,054 shares@ US$14.015.0% of flowCommon StockSEC:0001628280-24-043071:0
26,470 shares0Common StockSEC:0001628280-24-030363:0
7,737 shares0Common StockSEC:0000950170-24-073680:0
1,673 shares0Common StockSEC:0001209191-23-037910:0
10,483 shares0Common StockSEC:0000899243-23-011381:0